canakinumab
novartis
['canakinumab', 'lcsm,(-blcsm)']
impressive presidential session by . inflammation (il1 ) by pm2.5 as a promoter for egfr mutations in non-smokers. prevention using canakinumab works in the mice model, but reducing air pollution is probably the most important in the real world. #lcsm #esmo22 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC